| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/14/1997 | CA2245836A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 08/14/1997 | CA2245783A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | CA2245664A1 Enzyme detection biosensors |
| 08/14/1997 | CA2245650A1 Intracellular vitamin d binding protein |
| 08/13/1997 | EP0789081A2 Process for the genome amplification and mixtures of inducer oligonucleotides for the detection and identification of related infectious agents |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0788595A1 Method of testing immune competency |
| 08/13/1997 | EP0788557A1 Rapid detection and identification of nucleic acid variants and pathogens |
| 08/13/1997 | EP0788556A1 New polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms |
| 08/13/1997 | EP0788555A1 Methods of analysis and manipulation of dna utilizing mismatch repair systems |
| 08/13/1997 | EP0788554A1 Sequence analysis of saccharide material |
| 08/13/1997 | EP0788553A1 Microbiological test method and reagents |
| 08/13/1997 | EP0788552A1 Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| 08/13/1997 | EP0788543A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 08/13/1997 | EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 08/13/1997 | EP0788309A1 Reagents with enhanced performance in clinical diagnostic systems |
| 08/13/1997 | EP0725836B1 Probe and method for detecting yeasts of species candida krusei |
| 08/13/1997 | EP0689430B1 Superparamagnetic particles, process for producing the same and their use |
| 08/13/1997 | EP0668929B1 Quantitative detection of nucleic acid amplification products |
| 08/13/1997 | EP0566625B1 Method for extraction of intracellular components |
| 08/13/1997 | CN1156964A Novel Peptides |
| 08/12/1997 | US5656743 Antisense polynucleotide comprising at least one phosphorothioate linking group; antitumor agent, antiinflammatory agent |
| 08/12/1997 | US5656742 Ring-opened purine compounds for labeling polynucleotides |
| 08/12/1997 | US5656740 Diagnosis polypeptide |
| 08/12/1997 | US5656739 Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices |
| 08/12/1997 | US5656732 Polypeptides of feline T-cell lymphotrophic lentivirus |
| 08/12/1997 | US5656731 Nucleic acid-amplified immunoassay probes |
| 08/12/1997 | US5656728 Genetic engineering |
| 08/12/1997 | US5656725 Stabilize inappropriate cell proliferation or cell death |
| 08/12/1997 | US5656500 Liposomes coupled to molecules with biological activity selected from antigens, antibodies, and nucleic acids, these conjugate encapsulate hydrophilic polysubstituted aryl acridinium esters |
| 08/12/1997 | US5656495 Comprising dna encoding human topoisomerase i, promoter directing expression thereof, dna encoding repressor for promoter |
| 08/12/1997 | US5656493 System for automated performance of the polymerase chain reaction |
| 08/12/1997 | US5656462 Method for synthesizing cDNA using a polynucleotide immobilized support |
| 08/12/1997 | US5656461 Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA) |
| 08/12/1997 | US5656432 Genomic DNA fragment of Streptococcus pneumoniae, hybridization probe, amplification primer, reagent and method for the detection of Streptococcus pneumoniae |
| 08/12/1997 | US5656430 Detection mutations in nucleic acids |
| 08/12/1997 | US5656429 Polynucleotide and protein analysis method using magnetizable moieties |
| 08/12/1997 | US5656427 Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid |
| 08/12/1997 | US5656426 Functionaized hydrophilic acridinium esters |
| 08/12/1997 | US5656425 Detecting genetic disorder by generating the gene expressed hybrids with dna which had undergone segment deletion and replacement |
| 08/12/1997 | US5656424 Identification of mycobacterium tuberculosis complex species |
| 08/12/1997 | US5656423 Genetic engineering; urogenital cancer detection |
| 08/12/1997 | US5656422 Compositions and methods for detection of 2,4-dichlorophenoxyacetic acid and related compounds |
| 08/12/1997 | US5656207 Detecting or quantifying multiple analytes using labelling techniques |
| 08/12/1997 | US5656142 Thick film electrochemical device having insulating substrate and electrodes, and continuous moisture-absorbing electrolyte gel layer having enzyme-immobilized layer |
| 08/12/1997 | CA1339267C Felv-infected feline cell line |
| 08/12/1997 | CA1339266C Production of streptococcal m protein immunogens and molecular probes |
| 08/12/1997 | CA1339262C Detection of human papillomavirus by the polymerase chain reaction |
| 08/12/1997 | CA1339261C Hybridization probes for detecting neisseria strains |
| 08/12/1997 | CA1339260C Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
| 08/12/1997 | CA1339250C Method and apparatus for collecting and detecting microorganisms |
| 08/12/1997 | CA1339249C Method for sample adherence to test substrate |
| 08/07/1997 | WO1997028450A1 Methods for detecting colon cancer from stool samples |
| 08/07/1997 | WO1997028449A1 Method of determining the hepatic status of an individual, including a liver transplant recipient |
| 08/07/1997 | WO1997028446A1 Methods for detection and evaluation of bladder cancer |
| 08/07/1997 | WO1997028282A1 Improved primer-mediated polynucleotide synthesis and manipulation techniques |
| 08/07/1997 | WO1997028281A1 Method for assaying telomerase activity |
| 08/07/1997 | WO1997028280A1 Diagnostic method and apparatus |
| 08/07/1997 | WO1997028279A2 Positive controls for use in polynucleotide amplification |
| 08/07/1997 | WO1997028278A1 Use of primers for universal fingerprint analysis |
| 08/07/1997 | WO1997028276A1 Measurement of complement activation by biomaterials by means of complement convertase cleavage of peptide substrates |
| 08/07/1997 | WO1997028275A1 Electrochemiluminescence enzyme assay |
| 08/07/1997 | WO1997028262A1 Lyst1 and lyst2 gene compositions and methods of use |
| 08/07/1997 | WO1997028261A1 Tandem fluorescent protein constructs |
| 08/07/1997 | WO1997028250A1 Androgen-repressed metastatic human prostate cancer cell line |
| 08/07/1997 | WO1997028193A1 Compositions and methods useful in the detection and/or treatment of cancerous conditions |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028190A1 Cytokine antagonists and agonists |
| 08/07/1997 | WO1997028186A1 PURIFIED SR-p70 PROTEIN |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028177A1 Nucleoside analogues |
| 08/07/1997 | WO1997028176A1 Nucleoside analogues |
| 08/07/1997 | WO1997028175A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 08/07/1997 | WO1997027933A1 Fractionation using dielectrophoresis and field flow fractionation |
| 08/07/1997 | DE19602673A1 Synthetische Testanschmutzung Synthetic test stain |
| 08/07/1997 | DE19602662A1 Use of L-luciferin in bio-luminometric measurements |
| 08/07/1997 | DE19602335A1 Verfahren zum Schutz von Nukleinsäuren gegen eine Schädigung durch den Einfluß von UV-Licht A method of protecting against damage nucleic acids by the influence of UV light |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2246072A1 Method of determining the hepatic status of an individual, including a liver transplant recipient |
| 08/07/1997 | CA2245501A1 Use of primers for universal fingerprint analysis |
| 08/07/1997 | CA2244889A1 Androgen-repressed metastatic human prostate cancer cell line |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2244744A1 Lyst1 and lyst2 gene compositions and methods of use |
| 08/07/1997 | CA2243679A1 Nucleoside analogues |
| 08/07/1997 | CA2243637A1 Nucleoside analogues |
| 08/07/1997 | CA2243191A1 Diagnostic method and apparatus |
| 08/07/1997 | CA2242856A1 Methods for detection and evaluation of bladder cancer |
| 08/07/1997 | CA2217143A1 Positive controls for use in polynucleotide amplification |
| 08/06/1997 | EP0787989A2 Method for the preparation of a standardised plasma pool for diagnostic purposes |
| 08/06/1997 | EP0787807A2 Primers and probes for hepatitis C detection |
| 08/06/1997 | EP0787806A2 Abo glycosyltransferase sequence polymorphism |
| 08/06/1997 | EP0787805A2 Probe compositions for chromosome identification and method |
| 08/06/1997 | EP0787799A1 Staphylococcus aureus WCUH29 SpoIIIE Protein |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787300A1 STABILISING MEDIUM FOR $g(a)GST IN URINE FOR USE IN AN ENZYME IMMUNOASSAY |
| 08/06/1997 | EP0787210A1 Amplification and detection of mycobacterium avium complex species |
| 08/06/1997 | EP0787209A1 Method for amplifying nucleic acid sequences by translocation using chimeric primers |
| 08/06/1997 | EP0787208A1 A method for determining the integrity of nucleic acid |
| 08/06/1997 | EP0787206A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
| 08/06/1997 | EP0787205A1 Solid-phase nucleic acid amplification method and reagent kit therefor |